Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × surufatinib × Clear all

NCT05171439 2022-04-14

Surufatinib in Advanced Hepatocellular Carcinoma Based on Single-cell Sequencing of Tumor Samples

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT05282433 2022-03-16

Surufatinib Alone or Combined With Anti-PD-1 mAb in the Treatment of Advanced Hepatocellular Carcinoma

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular